XML 60 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Balance Sheet Accounts (Tables)
9 Months Ended
Mar. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Cash, Cash Equivalents, Short-Term Investments and Marketable Securities
Cash, Cash Equivalents, Short-Term Investments and Marketable Securities
Summary of Cash and Available-for-Sale Securities (in thousands)
 
 
March 31, 2014
 
June 30, 2013
Cash
$
70,668

 
$
41,518

 
 
 
 
Cash equivalents
$
687

 
$
54,285

Short-term investments
34,700

 
43,034

Marketable securities

 
66,776

Total available-for-sale
$
35,387

 
$
164,095

 
 
 
 
Total cash, cash equivalents and available for sale securities
$
106,055

 
$
205,613

Available-for-sale Securities
Available-for-Sale Securities
The following is a summary of available-for-sale securities (in thousands): 
 
Amortized
Cost
 
Fair Value
 
Unrealized
Holding
Gains
 
Unrealized
Holding
Losses
March 31, 2014
 
 
 
 
 
 
 
Money market funds
$
687

 
$
687

 
$

 
$

U.S. corporate debt securities
34,579

 
34,700

 
121

 

 
$
35,266

 
$
35,387

 
$
121

 
$

Classified as:
 
 
 
 
 
 
 
Cash equivalents
$
687

 
$
687

 
$

 
$

Short-term investments
34,579

 
34,700

 
121

 

 
$
35,266

 
$
35,387

 
$
121

 
$

June 30, 2013
 
 
 
 
 
 
 
Money market funds
$
54,285

 
$
54,285

 
$

 
$

U.S. corporate debt securities
110,078

 
109,810

 
126

 
(394
)
 
$
164,363

 
$
164,095

 
$
126

 
$
(394
)
Classified as:
 
 
 
 
 
 
 
Cash equivalents
$
54,285

 
$
54,285

 
$

 
$

Short-term investments
42,994

 
43,034

 
44

 
(4
)
Marketable securities
67,084

 
66,776

 
82

 
(390
)
 
$
164,363

 
$
164,095

 
$
126

 
$
(394
)
 
The amortized cost and estimated fair value of available-for-sale investments in debt securities at March 31, 2014, by contractual maturity, were as follows (in thousands):
 
 
Amortized
Cost
 
Fair
Value
Due in 1 year or less
$
24,697

 
$
24,803

Due in 1-2 years
7,553

 
7,568

Due in 2-5 years
3,016

 
3,016

Total investments in available for sale debt securities
$
35,266

 
$
35,387

Schedule of Goodwill
The following table reflects the changes in the carrying amount of goodwill (in thousands):

 
 
Total
Balance as of September 30, 2013
 
$

Addition due to acquisition of Enterasys (Note 4)
 
57,922

Balance as of December 31, 2013
 
$
57,922

Purchase price allocation adjustments
 
6,615

Balance as of March 31, 2014
 
$
64,537

Schedule of Indefinite-Lived Intangible Assets
The following tables present details of the Company’s intangible assets (in thousands):
March 31, 2014
 
Weighted average remaining amortization period
 
Gross
 
Accumulated amortization
 
Net
Intangible assets with finite lives:
 
 
 
 
 
 
 
 
Developed technology
 
2.4 years
 
$
45,000

 
$
6,736

 
$
38,264

Customer relationships
 
2.6 years
 
37,000

 
5,139

 
31,861

Maintenance contracts
 
4.6 years
 
17,000

 
1,417

 
15,583

Trademarks
 
2.6 years
 
2,500

 
347

 
2,153

Order backlog
 
1.0 year
 
7,400

 
4,542

 
2,858

License agreements
 
10.9 years
 
10,447

 
7,971

 
2,476

Other intangibles
 
5.2 years
 
2,459

 
1,449

 
1,010

Total intangible assets with finite lives
 
 
 
121,806

 
27,601

 
94,205

In-process research and development, with indefinite life
 
 
 
3,000

 

 
3,000

Total
 
 
 
$
124,806

 
$
27,601

 
$
97,205

Schedule of Finite-Lived Intangible Assets
The following tables present details of the Company’s intangible assets (in thousands):
March 31, 2014
 
Weighted average remaining amortization period
 
Gross
 
Accumulated amortization
 
Net
Intangible assets with finite lives:
 
 
 
 
 
 
 
 
Developed technology
 
2.4 years
 
$
45,000

 
$
6,736

 
$
38,264

Customer relationships
 
2.6 years
 
37,000

 
5,139

 
31,861

Maintenance contracts
 
4.6 years
 
17,000

 
1,417

 
15,583

Trademarks
 
2.6 years
 
2,500

 
347

 
2,153

Order backlog
 
1.0 year
 
7,400

 
4,542

 
2,858

License agreements
 
10.9 years
 
10,447

 
7,971

 
2,476

Other intangibles
 
5.2 years
 
2,459

 
1,449

 
1,010

Total intangible assets with finite lives
 
 
 
121,806

 
27,601

 
94,205

In-process research and development, with indefinite life
 
 
 
3,000

 

 
3,000

Total
 
 
 
$
124,806

 
$
27,601

 
$
97,205



June 30, 2013
 
Weighted average remaining amortization period
 
Gross
 
Accumulated amortization
 
Net
Intangible assets with finite lives:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
License agreements
 
10.3 years
 
10,447

 
7,407

 
3,040

Other intangibles
 
5.8 years
 
2,459

 
1,256

 
1,203

Total intangible assets with finite lives
 
 
 
12,906

 
8,663

 
4,243

Future Amortization Expense
The estimated future amortization expense for finite lived intangibles to be recorded for each of the next five years is as follows (in thousands):

Fiscal year
 
Amount
2014 (remaining 3 months)
 
$
9,540

2015
 
34,648

2016
 
31,286

2017
 
12,379

2018
 
3,682

2019
 
1,415

Thereafter
 
1,255

Total
 
$
94,205

Schedule of Deferred Revenue, Net
The following table summarizes deferred revenue, net at March 31, 2014 and June 30, 2013, respectively (in thousands):
 
 
March 31, 2014
 
June 30, 2013
Deferred services
$
84,206

 
$
38,003

Deferred product and other revenue
6,644

 
3,451

Total deferred revenue
90,850

 
41,454

Less: current portion
71,183

 
33,184

Non-current deferred revenue, net
$
19,667

 
$
8,270

Change in Deferred Support Revenue
The change in the Company’s deferred support revenue balance in relation to these arrangements was as follows (in thousands):
 
 
Three Months Ended
 
Nine Months Ended
 
March 31, 2014
 
March 31, 2013
 
March 31, 2014
 
March 31, 2013
Balance beginning of period
$
81,485

 
$
35,797

 
$
38,003

 
$
37,461

Assumed from acquisition

 

 
35,879

 

New support arrangements
30,986

 
14,431

 
77,475

 
41,745

Recognition of support revenue
(28,265
)
 
(13,420
)
 
(67,151
)
 
(42,398
)
Balance end of period
84,206

 
36,808

 
84,206

 
36,808

Less: current portion
64,539

 
28,801

 
64,539

 
28,801

Non-current deferred revenue
$
19,667

 
$
8,007

 
$
19,667

 
$
8,007

Schedule of Deferred Distributors Revenue
The following table summarizes deferred distributors revenue, net of cost of sales to distributors at March 31, 2014 and June 30, 2013, respectively (in thousands):
 
March 31, 2014
 
June 30, 2013
Deferred distributors revenue
$
31,070

 
$
22,411

Deferred cost of sales to distributors
(6,853
)
 
(5,023
)
Deferred distributors revenue, net of cost of sales to distributors
$
24,217

 
$
17,388

Schedule of Debt
The Company's debt is comprised of the following:

 
 
March 31, 2014
Current portion of long-term debt:
 
 
Term Loan
 
4,875

Revolving Facility
 
24,000

Current portion of long-term debt
 
28,875

 
 
 
Long-term debt, less current portion:
 
 
Term Loan
 
58,500

Revolving Facility
 
35,000

Total long-term debt, less current portion
 
93,500

Total debt
 
122,375

Schedule of Product Warranty Liability
The following table summarizes the activity related to the Company’s product warranty liability during the three and nine months ended March 31, 2014 and 2013:
 
 
Three Months Ended
 
Nine Months Ended
 
March 31, 2014
 
March 31, 2013
 
March 31, 2014
 
March 31, 2013
Balance beginning of period
$
7,479

 
$
2,971

 
$
3,296

 
$
2,871

Assumed from acquisition

 

 
3,732

 

New warranties issued
1,824

 
1,257

 
4,782

 
4,761

Warranty expenditures
(1,478
)
 
(1,332
)
 
(3,985
)
 
(4,736
)
Balance end of period
$
7,825

 
$
2,896

 
$
7,825

 
$
2,896

Schedules of Concentration of Risk, by Risk Factor
The following table sets forth major customers accounting for 10% or more of our net revenue:
 
 
Three Months Ended
 
Nine Months Ended
 
 
March 31, 2014
 
March 31, 2013
 
March 31, 2014
 
March 31, 2013
Tech Data
 
16
%
 
11
%
 
12
%
 
*

Westcon Group Inc.
 
14
%
 
19
%
 
13
%
 
10
%
Scansource, Inc.
 
*

 
10
%
 
*

 
*

 
 
 
 
 
 
 
 
 
* Less than 10% of revenue